STOCK TITAN

II-VI Incorporated Introduces Multi-Wavelength Laser Modules for Life Sciences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

II-VI Incorporated (Nasdaq: IIVI) has launched a new line of multi-wavelength laser modules aimed at life sciences applications, responding to the demand for versatile photonics-based instruments. These modules can feature up to four lasers with output power ranging between 1 mW to 5 W and maintain over 80% near-field intensity uniformity. With ISO-certified facilities, II-VI emphasizes its commitment to high-quality production, supporting various life sciences applications including imaging systems and flow cytometers. The company will present its products at the 2021 SPIE BiOS Digital Marketplace, scheduled for March 6-11, 2021.

Positive
  • Launch of new multi-wavelength laser modules for life sciences applications.
  • Modules offer high performance with output power ranging from 1 mW to 5 W.
  • Maintains over 80% near-field intensity uniformity.
  • ISO-certified production facilities ensure high-quality manufacturing.
Negative
  • None.

PITTSBURGH, Feb. 18, 2021 (GLOBE NEWSWIRE) -- II‐VI Incorporated (Nasdaq: IIVI), a leader in laser technology and subsystems, today announced the introduction of its multi-wavelength laser module product line for life sciences.

The rapidly growing number of photonics-based instruments for life sciences, including fluorescence-based imaging systems, flow cytometers, and DNA sequencers, is driving the demand for multi-functional laser product platforms that can be easily reconfigured while still delivering very high performance. II-VI’s multi-wavelength laser modules can be configured with up to four lasers in many visible wavelength combinations and maintain outstanding near-field intensity uniformity of greater than 80% with output power ranging from 1 mW to 5 W, making them well-suited for a broad range of life sciences instruments.

“The widespread reliance on PCR testing for COVID-19 showcases how instruments for life sciences have increasingly come to rely on high-quality light sources and optics, and we believe that this trend will continue to accelerate,” said Dr. Sanjai Parthasarathi, Chief Marketing Officer. “Leveraging our core competency in thermoelectrics and photonics, along with our ISO-certified biomedical assembly facilities, our highly experienced new production introduction teams provide our customers in life sciences with world-class turnkey support from product concept to volume production.”

II-VI’s multi-wavelength laser modules can be custom-configured with up to four wavelengths in the visible – blue (405/450/465/488 nm), green (520/532 nm), or red (640/660 nm). They are fully integrated with an ARM microcontroller to enable software configuration and remote monitoring. Compact and customizable, II-VI’s modules deliver the highest-quality performance and reliability. They can be easily integrated into instrumentation platforms for a wide range of life sciences applications.

II-VI’s broad portfolio of products for instrumentation in life sciences includes visible-wavelength lasers, precision optics, filters, assemblies, and thermoelectric modules. System providers can expand assembly manufacturing at II-VI’s facilities in Dallas, Texas; Fuzhou, China; and Ho Chi Minh City, Vietnam, which are certified to ISO 13485 for biomedical assemblies.

II-VI will showcase its broad product line of optics and lasers for life sciences at the 2021 SPIE BiOS Digital Marketplace, March 6-11, 2021.

About II-VI Incorporated

II-VI Incorporated, a global leader in engineered materials and optoelectronic components, is a vertically integrated manufacturing company that develops innovative products for diversified applications in communications, materials processing, aerospace & defense, semiconductor capital equipment, life sciences, consumer electronics, and automotive markets. Headquartered in Saxonburg, Pennsylvania, the Company has research and development, manufacturing, sales, service, and distribution facilities worldwide. The Company produces a wide variety of application-specific photonic and electronic materials and components, and deploys them in various forms, including integrated with advanced software to support our customers. For more information, please visit us at www.ii-vi.com.

CONTACT:      Mark Lourie
 Vice President, Corporate Communications
 corporate.communications@ii-vi.com
 www.ii-vi.com/contact-us 

FAQ

What new product did II-VI introduce for life sciences?

II-VI introduced a multi-wavelength laser module product line tailored for life sciences applications.

What are the key features of II-VI's multi-wavelength laser modules?

The modules can be configured with up to four lasers, maintain over 80% near-field intensity uniformity, and provide output power between 1 mW and 5 W.

When will II-VI showcase its new products?

II-VI will showcase its product line at the 2021 SPIE BiOS Digital Marketplace from March 6-11, 2021.

How does II-VI support its customers in life sciences?

II-VI provides turnkey support from product concept to volume production, leveraging its expertise in thermoelectrics and photonics.

What applications are targeted by II-VI's new laser modules?

The laser modules are designed for a range of life sciences instruments, including fluorescence-based imaging systems and flow cytometers.

IIVI

NYSE:IIVI

IIVI Rankings

IIVI Latest News

IIVI Stock Data

2.30M
Optical Instrument and Lens Manufacturing
Manufacturing
Link
US
Saxonburg